Boston Scientific Files 8-K on Financials

Ticker: BSX · Form: 8-K · Filed: Oct 23, 2024 · CIK: 885725

Boston Scientific CORP 8-K Filing Summary
FieldDetail
CompanyBoston Scientific CORP (BSX)
Form Type8-K
Filed DateOct 23, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.01
Sentimentneutral

Sentiment: neutral

Topics: financial-reporting, results-of-operations

Related Tickers: BSX

TL;DR

BSX filed an 8-K on Oct 23 detailing financial results.

AI Summary

Boston Scientific Corporation filed an 8-K on October 23, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits related to the company's performance. The report details information as of October 23, 2024.

Why It Matters

This filing provides investors with crucial updates on Boston Scientific's financial health and operational performance, impacting investment decisions.

Risk Assessment

Risk Level: low — This is a routine financial reporting filing and does not indicate any immediate or unusual risks.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report on Boston Scientific Corporation's results of operations and financial condition.

When was this 8-K filing submitted?

This 8-K filing was submitted on October 23, 2024.

What is Boston Scientific Corporation's state of incorporation?

Boston Scientific Corporation is incorporated in Delaware.

What is the IRS Employer Identification Number for Boston Scientific Corporation?

The IRS Employer Identification Number for Boston Scientific Corporation is 04-2695240.

What is the business address of Boston Scientific Corporation?

The business address of Boston Scientific Corporation is 300 Boston Scientific Way, Marlborough, Massachusetts 01752-1234.

Filing Stats: 515 words · 2 min read · ~2 pages · Grade level 11.6 · Accepted 2024-10-23 06:32:53

Key Financial Figures

Filing Documents

02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION

ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION. On October 23, 2024, Boston Scientific Corporation issued a press release announcing financial results for the third quarter ended September 30, 2024. A copy of the release is furnished with this report as Exhibit 99.1. The information contained in Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.

01. FINANCIAL STATEMENTS AND EXHIBITS

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS. (d) Exhibits Exhibit No. Description 99.1 Press Release issued by Boston Scientific Corporation dated October 23, 2024 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 23, 2024 BOSTON SCIENTIFIC CORPORATION By: /s/ Susan Thompson Susan Thompson Vice President, Chief Corporate Counsel and Assistant Secretary

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing